Hyperlipidemia

Episodes 33-36 of 36

• 

  RestartResume

  Mechanistic clues to understanding the benefits of icosapent ethyl
  

  RestartResume

  Mechanistic clues to understanding the benefits of icosapent ethyl
  

  MinuteCE®

  Mechanistic clues to understanding the benefits of icosapent ethyl
  

  1.00 program credit

  • 

    

    Matthew Jay Budoff, MD

  1.00 program credit

• 

  RestartResume

  Addressing late-breaking data on triglycerides, fibrates and omega-3 FAs
  

  RestartResume

  Addressing late-breaking data on triglycerides, fibrates and omega-3 FAs
  

  MinuteCE®

  Addressing late-breaking data on triglycerides, fibrates and omega-3 FAs
  

  1.00 program credit

  • 

    

    Peter Libby, MD

  • 

    

    P. Gabriel Steg, MD

  • 

    

    Kausik Ray, MBChB, MD, MPhil

  1.00 program credit

• 

  MinuteCE®

  Tackling risk reduction in ASCVD: Sharing international experience

  1.00 credit 3 episodes

  • 

    

    Matthew Jay Budoff, MD

  • 

    

    Lawrence A. Leiter, MD

  • 

    

    Peter Libby, MD

  • 

    

    P. Gabriel Steg, MD

  • 

    

    Kausik Ray, MBChB, MD, MPhil

  1.00 credit 3 episodes

• 

  RestartResume

  Tackling risk reduction in ASCVD: A clinical case  
  

  RestartResume

  Tackling risk reduction in ASCVD: A clinical case  
  

  MinuteCE®

  Tackling risk reduction in ASCVD: A clinical case  
  

  1.00 program credit

  • 

    

    Lawrence A. Leiter, MD

  1.00 program credit